CYTOMX THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

11 2 2025 09:45:11 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

10 2 2025 10:47:26 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

15 1 2025 11:19:23 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

14 1 2025 11:58:53 提供 NetDania Notify

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

06 1 2025 16:05:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

27 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

19 11 2024 09:56:48 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

18 11 2024 09:58:03 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

15 11 2024 09:54:07 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

11 11 2024 10:14:07 提供 NetDania Notify

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

07 11 2024 16:10:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

06 11 2024 14:45:07 提供 NetDania Notify

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

31 10 2024 08:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

29 10 2024 15:57:21 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

28 10 2024 11:30:57 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

25 10 2024 11:27:19 提供 NetDania Notify

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

09 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

04 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

08 8 2024 16:10:00 提供 Nasdaq GlobeNewswire